MLTX vs WST · $1.41B cap vs P/E 35, rev $1.72B
MoonLake Immunotherapeutics (MLTX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
MoonLake Immunotherapeutics (MLTX) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
MLTX does not have a complete income-statement cache yet.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
MLTX currently screens at market cap $1.41B. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the MLTX and WST stock pages for the full models.
Not investment advice.